96 related articles for article (PubMed ID: 17115102)
21. Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant beta-catenin expression.
Lantsov D; Meirmanov S; Nakashima M; Kondo H; Saenko V; Naruke Y; Namba H; Ito M; Abrosimov A; Lushnikov E; Sekine I; Yamashita Sh
Histopathology; 2005 Sep; 47(3):248-56. PubMed ID: 16115225
[TBL] [Abstract][Full Text] [Related]
22. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
Nucera C; Eeckhoute J; Finn S; Carroll JS; Ligon AH; Priolo C; Fadda G; Toner M; Sheils O; Attard M; Pontecorvi A; Nose V; Loda M; Brown M
Clin Cancer Res; 2009 Jun; 15(11):3680-9. PubMed ID: 19470727
[TBL] [Abstract][Full Text] [Related]
23. Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization.
Cho EY; Choi YL; Han JJ; Kim KM; Oh YL
Pathol Int; 2008 Jan; 58(1):17-25. PubMed ID: 18067636
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
[TBL] [Abstract][Full Text] [Related]
25. Expression and mutation analysis of the tyrosine kinase c-kit in poorly differentiated and anaplastic thyroid carcinoma.
Broecker-Preuss M; Sheu SY; Worm K; Feldkamp J; Witte J; Scherbaum WA; Mann K; Schmid KW; Schott M
Horm Metab Res; 2008 Oct; 40(10):685-91. PubMed ID: 18622894
[TBL] [Abstract][Full Text] [Related]
26. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer.
Melck A; Masoudi H; Griffith OL; Rajput A; Wilkins G; Bugis S; Jones SJ; Wiseman SM
Ann Surg Oncol; 2007 Dec; 14(12):3403-11. PubMed ID: 17882495
[TBL] [Abstract][Full Text] [Related]
27. Multidrug resistance gene and P-glycoprotein expression in anaplastic carcinoma of the thyroid.
Yamashita T; Watanabe M; Onodera M; Shimaoka K; Ito K; Fujimoto Y; Itoyama S; Sugawara I
Cancer Detect Prev; 1994; 18(5):407-13. PubMed ID: 7812988
[TBL] [Abstract][Full Text] [Related]
28. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features.
Odajima T; Sasaki Y; Tanaka N; Kato-Mori Y; Asanuma H; Ikeda T; Satoh M; Hiratsuka H; Tokino T; Sawada N
Hum Pathol; 2005 Mar; 36(3):234-41. PubMed ID: 15791567
[TBL] [Abstract][Full Text] [Related]
29. Beta- and gamma-catenin expression in thyroid carcinomas.
Cerrato A; Fulciniti F; Avallone A; Benincasa G; Palombini L; Grieco M
J Pathol; 1998 Jul; 185(3):267-72. PubMed ID: 9771480
[TBL] [Abstract][Full Text] [Related]
30. [Anaplastic carcinoma of the thyroid at the Instituto Nacional de la Nutrición Salvador Zubirán].
Sierra M; Gamboa-Domínguez A; Herrera MF; Barredo-Prieto B; Alvarado de la Barrera C; Llorente L; Pérez-Enriquez B; Rivera R; González O; Rull JA
Rev Invest Clin; 1997; 49(2):97-103. PubMed ID: 9380971
[TBL] [Abstract][Full Text] [Related]
31. Morphoproteomics demonstrates activation of mTOR pathway in anaplastic thyroid carcinoma: a preliminary observation.
Liu J; Brown RE
Ann Clin Lab Sci; 2010; 40(3):211-7. PubMed ID: 20689131
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
[TBL] [Abstract][Full Text] [Related]
33. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions.
Brzeziańska E; Cyniak-Magierska A; Sporny S; Pastuszak-Lewandoska D; Lewiński A
Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985
[TBL] [Abstract][Full Text] [Related]
34. Relations between cyclin D1 and chromosome 11 in thyroid carcinoma: analysis by dual stain using FISH and immunostaining method.
Jikuzono T; Tenjin T; Shimizu K
J Nippon Med Sch; 2009 Apr; 76(2):54-5. PubMed ID: 19443989
[TBL] [Abstract][Full Text] [Related]
35. Editorial: anaplastic carcinoma of the thyroid--will aurora B light a path for treatment?
Nikiforov YE
J Clin Endocrinol Metab; 2005 Feb; 90(2):1243-5. PubMed ID: 15699543
[No Abstract] [Full Text] [Related]
36. [Research advances in molecular pathogenesis of thyroid cancer].
Aleha M; Meng QB; Yu JC; Kang WM; Cao ZJ; Tian SB
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):382-5. PubMed ID: 23987483
[TBL] [Abstract][Full Text] [Related]
37. Cyclin D1 in thyroid carcinomas.
Shi Y; Zou M; Varkondi E; Nagy A; Kozma L; Farid NR
Thyroid; 2001 Jul; 11(7):709-10. PubMed ID: 11484902
[No Abstract] [Full Text] [Related]
38. Gene expression in thyroid tumors.
Puskas L; Farid NR
Cancer Treat Res; 2004; 122():265-71. PubMed ID: 16209050
[No Abstract] [Full Text] [Related]
39. Integrated analysis of multiscale large-scale biological data for investigating human disease.
Huang T; Chen L; Zheng M; Song J
Biomed Res Int; 2015; 2015():760765. PubMed ID: 25973424
[No Abstract] [Full Text] [Related]
40. Anaplastic thyroid carcinoma. Immunocytochemical study of 32 cases.
Ordóñez NG; El-Naggar AK; Hickey RC; Samaan NA
Am J Clin Pathol; 1991 Jul; 96(1):15-24. PubMed ID: 1712540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
